Breaks Categories: News

ThursdayMar 01, 2018 9:18 am

CannabisNewsBreaks – Hiku Brands Company Ltd. (CSE: HIKU) (OTC: DJACF) Subsidiary Completes Pre-Sales Inspection at West Kelowna

Canada’s first vertically-integrated cannabis brand house, Hiku Brands Company Ltd. (CSE: HIKU) (OTC: DJACF), through its DOJA Cannabis Ltd. subsidiary, this morning announced that it has completed Health Canada’s pre-sales license inspection of its West Kelowna facility. Per the update, Health Canada inspectors were onsite at the West Kelowna project throughout a three-day period ended on February 15, 2018, in an effort to verify the information submitted by DOJA as part of its application and assess the company’s compliance with applicable sections of the Access to Cannabis for Medical Purposes Regulations. This milestone is particularly noteworthy as it coincides with…

Continue Reading

ThursdayMar 01, 2018 9:13 am

CannabisNewsBreaks – PotNetwork Holding Inc. (POTN) Subsidiary Achieves Over $3M in Sales; Company Revamps Corporate Website

Cannabidiol-focused holding company PotNetwork Holding (OTC: POTN) this morning said that its wholly-owned subsidiary, Diamond CBD, Inc., has exceeded $3 million in sales in the first 45 days of 2018. Additionally, the company’s website has recently been renovated into a cleaner, more user-friendly site that now includes real time information regarding revenue results. “We believe this is a great way to demonstrate our commitment to transparency. As revenues grow, they will be quickly available online for public viewing. Also featured is a comparison with the corresponding sales results of the prior year, giving investors an excellent resource for gauging our…

Continue Reading

WednesdayFeb 28, 2018 1:25 pm

CannabisNewsBreaks – Global Payout, Inc. (GOHE) Subsidiary Announces Launch of Integrated Philanthropic Company

Payment solutions company Global Payout, Inc. (OTC: GOHE), through its SecurCapital Corp. subsidiary, today announced the launch of its integrated philanthropic company, SecurFoundation. The new initiative is focused on improving communities around the world by designating one percent of SecurCapital’s capital structure, products, earnings and employees’ time for charitable causes. “Every company has a responsibility for allocating some of their assets to the social good,” Steve Russell, chairman of SecurCapital, stated in the news release. “This can apply in so many ways, such as providing internships for better job training and opportunities or supporting events that raise funds for good…

Continue Reading

WednesdayFeb 28, 2018 10:57 am

CannabisNewsBreaks – EVIO, Inc. (EVIO) Announces Aggressive Expansion Strategy that will Double its Cannabis Testing Facilities in 2018

This morning, EVIO, Inc. (OTCQB: EVIO), a leading cannabis testing company, announced its aggressive expansion strategy to double its number of accredited cannabis testing facilities from nine to 18 in 2018.  In the press release, EVIO reported that the expansion will be spearheaded by two of its recently recruited team players. Albert Lustig will serve as the president, and Ron Russak will serve as the vice president of operations. According to EVIO CEO William Waldrop, Lustig will be instrumental in driving growth in both new and existing markets through the execution of the company’s national and international sales and operational…

Continue Reading

WednesdayFeb 28, 2018 10:44 am

CannabisNewsBreaks – Earth Science Tech, Inc. (ETST) Finalizes Plans for Human Trial of CBD-based Formula Targeting Opioid Addiction

Earth Science Tech, Inc. (OTC: ETST) this morning reported that it has finalized preparations for its nine-month human trial to evaluate the effectiveness of a blend of broad-spectrum cannabinoid industrial hemp oil and essential mineral element. The trial seeks to develop a CBD formulation for the treatment of opioid addicts, relieving withdrawal symptoms, and averting fatal overdoses. ETST aims to increase the potency of its formulation by combining its full-spectrum cannabinoids industrial hemp oil with essential minerals. The trial is scheduled to be completed in 2019 and it will be supervised by ETST chief learning officer Gabriel Aviles and CEO…

Continue Reading

WednesdayFeb 28, 2018 10:14 am

CannabisNewsBreaks – PotNetwork Holding Inc. (POTN) Featured in New Market Research Report

Cannabidiol-focused holding company PotNetwork Holding Inc. (OTC: POTN) was this morning announced as the subject of a comprehensive research report by independent equity research firm Traders News Source. The report notes that, in late December 2017, POTN shares were trading at $0.06, but the company’s PPS has hit record highs in the months since. In late January, POTN shares hit a high of $0.85, and POTN continue to trade near $0.48 per share. Traders News Source attributes this performance to a number of factors, including sustained revenue growth, POTN’s introduction of new product lines through its subsidiaries and the favorable…

Continue Reading

WednesdayFeb 28, 2018 10:11 am

CannabisNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Releases Stock Dividend Details Regarding Spinoff of Hemp-related Assets

Market analysis company ChineseInvestors.com (OTCQB: CIIX) this morning released details of the stock dividends related to the company’s anticipated spinoff of its hemp-related assets including its China-based wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. and its wholly owned United States subsidiaries, ChineseHempOil.com, Inc. and Hemp Logic, Inc. In January, the subsidiaries attained combined sales of over $100,000.00 and are well positioned to continue to achieve significant growth in the future. The company intends to combine the three subsidiaries into a single private company and bring it to the public market in the 12 to 18 months that follow. The…

Continue Reading

WednesdayFeb 28, 2018 9:26 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Adds Senior Vice President of Marketing

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced its appointment of Chris Gagan to the position of Senior Vice President of Marketing in a move that’s expected to play a key role in refining the company’s brand strategy. Gagan bring more than two decades of marketing and brand development experience to Choom, having previously led the design and development team for Canada’s largest national retailer of sporting goods, FGL Sports. As Choom’s Senior Vice President of Marketing, Gagan will provide leadership and guidance related to the execution of the company’s marketing efforts, as…

Continue Reading

WednesdayFeb 28, 2018 9:25 am

CannabisNewsBreaks – Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) Inks MOU with BioCan Technologies

Veritas Pharma (CSE: VRT) (OTC: VRTHF) (FRT: 2VP), a pharmaceutical and IP development firm, this morning announced that it has entered into a Memorandum of Understanding (“MOU”) with BioCan Technologies Inc. of Calgary, Alberta to collaborate exclusively to conduct additional investigations of cannabis strains being developed by Veritas’ research arm, Cannevert Therapeutics Ltd. (“CTL”). Optimizing the genetics of the cannabis plants for scientific and clinical testing over the next two years is the company’s primary focus during the collaboration. Definitive agreements relating to the MOU are anticipated to be signed by July 31, 2018. “BioCan’s geneticists will help CTL scientists…

Continue Reading

TuesdayFeb 27, 2018 3:33 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) CEO, Chief Research Officer Discuss Company’s Response to Opioid Epidemic

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) was featured in an interview today by Proactive Investors. Chairman and CEO Stephen Van Deventer and chief research officer Dr. Harry Parekh discussed the company’s four programs: Sol-Gel, Nature Identical™, Dual Gene Therapy and Engineering Peptide Therapeutics. Among other topics, they discuss the rising rate of opioid overdoses and addiction, which the company’s planning to tackle utilizing its proprietary linker technology to engineer peptide therapeutics. “What's key about the technology is you cannot create tolerance to this treatment and you cannot overdose as well,” PreveCeutical chairman and CEO…

Continue Reading